Navigation Links
Sunesis Pharmaceuticals Presents Data from Clinical Trials of Voreloxin (formerly SNS-595) in Patients with Acute Myeloid Leukemia at the 13th Congress of the European Hematology Association
Date:6/16/2008

>SUNESIS and the logo are trademarks of Sunesis Pharmaceuticals, Inc.

Safe Harbor Statement

This press release contains forward-looking statements including without limitation statements related to the potential safety, efficacy, duration of response and commercial potential of voreloxin (formerly SNS-595); planned additional clinical testing and development efforts for voreloxin; the timing of enrollment in the ongoing clinical trials of voreloxin; and the timing of announcements of results of ongoing clinical trials of voreloxin. Words such as "promising," "encouraging," "hope," "appears," "demonstrate," "indicates," "supports," and "look forward" and similar expressions are intended to identify forward-looking statements. These forward-looking statements are based upon Sunesis' current expectations. Forward-looking statements involve risks and uncertainties. Sunesis' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, the risk that Sunesis' development activities for voreloxin, including enrollment and reporting of results, could be halted significantly or delayed for various reasons; the risk that Sunesis' clinical trials for voreloxin may not demonstrate safety or efficacy or lead to regulatory approval; the risk that preliminary data and trends including data regarding duration of response, may not be predictive of future data or results; the risk that Sunesis' preclinical studies and clinical trials may not satisfy the requirements of the FDA or other regulatory agencies; risks related to the conduct of Sunesis' clinical trials and manufacturing; and risks related to Sunesis' need for additional funding. These and other risk factors are discussed under "Risk Factors" and elsewhere in Sunesis' Annual Report on Form 10-K for the year ended December 31, 2007, Sunesis' Quarterly Report on Form 10-Q fo
'/>"/>

SOURCE Sunesis Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Sunesis Pharmaceuticals Focuses Resources on Development of Voreloxin (Formerly SNS-595)
2. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
3. Sunesis Pharmaceuticals to Present Interim Clinical Data From Voreloxin (Formerly SNS-595) Ovarian Cancer Trial at 44th ASCO Annual Meeting and Acute Myeloid Leukemia Trials at 13th EHA Congress
4. Sunesis Pharmaceuticals Initiates Phase 2 Clinical Trial of Voreloxin (SNS-595) in Acute Myeloid Leukemia
5. Sunesis Pharmaceuticals Reports Data from Nonclinical Studies of SNS-032 at the Annual Meeting of the American Association for Cancer Research
6. Sunesis Pharmaceuticals to Present Non-Clinical Data at the Annual Meeting of the American Association for Cancer Research
7. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
8. Sunesis Pharmaceuticals to Present Data on Two Product Candidates at the 49th Annual Meeting of the American Society of Hematology
9. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
10. Sunesis Pharmaceuticals Commences Clinical Trials of SNS-595 and SNS-314
11. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... 2014  Decision Resources Group finds that, for ... Brazil and Mexico ... prescribe long-acting beta-agonist (LABA)- and long-acting muscarinic antagonist ... current severe cost/coverage constraints. Therefore, new brands of ... launch in these countries—which will considerably expand the ...
(Date:8/21/2014)... , Aug. 21, 2014 /PRNewswire-iReach/ -- ScriptPro ... Alliance (HITRUST) under its Common Security Framework (CSF). ... Security and Privacy Manager, "We appreciate this rigorous, ... of commitment that this certification signifies. Our business ... ABOUT THE CSF CERTIFICATION PROCESS: ScriptPro,s internal ...
(Date:8/21/2014)... 21, 2014 BreedIT Corp., ... the exclusive worldwide license holder and distributor of ... and researchers, today is pleased to announce the ... Seach Ltd, a leading Israeli medical Cannabis breeder. ... develop new breeds of medical Cannabis to meet ...
Breaking Medicine Technology:Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 2Novel Fixed-Dose Combinations for COPD in Brazil and Mexico Will Compete With Well-Established Therapies in an Environment Dominated by Aggressive Cost-Control Mechanisms 3ScriptPro Achieves HITRUST Certification 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 2BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 3BreedIT Ltd. and Seach Ltd. Form KanaboSeed to Develop New Medical Cannabis Varieties 4
... 2011 Nearly three quarters of the ... imported from developed markets, but the next wave of growth ... the unique needs of the India market, according to preliminary ... , which were presented today at AdvaMed 2011, the annual ...
... Sparta Systems, Inc. , the maker of TrackWise® ... enterprise quality and compliance management solutions, today announced ... its TrackWise enterprise quality management software ... of the comprehensive TrackWise solution reduces user administrative ...
Cached Medicine Technology:Made in India, for India, is Next Wave of Growth for Region's Medical Technology Sector 2Made in India, for India, is Next Wave of Growth for Region's Medical Technology Sector 3Next Generation of TrackWise® Enterprise Quality Management Software Delivers Enhanced Web Services Functionality for Global Organizations 2Next Generation of TrackWise® Enterprise Quality Management Software Delivers Enhanced Web Services Functionality for Global Organizations 3
(Date:8/21/2014)... The report "Industrial Flue Gas ... System (FGD, DeNOx, Particulate Control, Mercury Control) by ... & Others) - Global Trends & Forecasts to ... gas treatment systems & services market with analysis ... terms of value. The industrial flue gas treatment ...
(Date:8/21/2014)... August 21, 2014 According to a ... Audio Equipment (Product Types - Home Theatre in-a-box, Home ... - Global Industry Analysis, Size, Share, Growth, Trends and ... USD 15.94 billion in 2012 and is expected to ... CAGR of 3.7% from 2013 to 2019. Europe was ...
(Date:8/21/2014)... Revista, a one-stop source for healthcare ... is “on a roll.” Today, the Annapolis-based company ... Southeast, Mid-Atlantic and Midwest areas of the country ... available, comprehensive medical property database tracking these regions. ... including existing and recently added, is 34,549. This ...
(Date:8/21/2014)... August 21, 2014 American Addiction Centers, ... services for individuals with drug and/or alcohol addiction, has ... Fastest Growing Private Companies. , The company is ranked ... the list and 4th on the list in the ... growth of 995%, American Addiction Centers (AAC) ascended to ...
(Date:8/21/2014)... Steven Reinberg HealthDay Reporter ... of U.S. teens using sunscreen dropped nearly 12 percent in ... same time period, the number of teens using indoor tanning ... sunscreen increase the risk of skin cancers, including deadly melanomas, ... the overall percentage of teens who reported wearing sunscreen, from ...
Breaking Medicine News(10 mins):Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 2Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 3Health News:Industrial Flue Gas Treatment Systems Market Estimated to Worth $59, 546.7 Million by 2019 – Report by MarketsandMarkets 4Health News:Home Audio Equipment Market Expected to Reach USD 20.68 Billion in 2019 2Health News:Home Audio Equipment Market Expected to Reach USD 20.68 Billion in 2019 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 2Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 3Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 4Health News:Revista Medical Property Data Now Available for the Mid-Atlantic, Southeast and Midwest Regions 5Health News:American Addiction Centers Named to Inc. 500 List Recognition for Three-Year Sales Growth of 995% 2Health News:Fewer U.S. Teens Using Sunscreen, Study Finds 2
... Statement from Stephen J. Nolan, Chairman of the ... Dr. Edward Livingston Trudeau founded our health organization and ... Association joins thousands of individuals around the globe in ... the lives and struggles of people affected by TB ...
... MAITLAND, Fla., March 24 Florida farmers have launched ... initial round of $160,000 in funding for three programs ... the farmworker community in South Florida. For its inaugural ... chosen to work with Collier Health Services ...
... of the most useful and established enteral nutrition ... surgical technique and is mainly performed in elderly ... adverse events is higher compared to other methods ... often encounter enteral nutrition problems after surgery. Although ...
... are significantly more at risk of losing their eyesight and losing ... same condition. , A UK study carried out by the ... more prevalent in South Asians and occurs earlier than in White ... the latest issue of Diabetes Care , looked at 1.035 ...
... reveal that laser technology is steering the future of ... Cosmetic Surgery (AACS), a leader in the cosmetic surgery ... notable finding is the shift towards non-invasive laser treatments. ... surgeons have seen a significant increase in both males ...
... the world dedicated to breast reconstruction for women facing breast ... 182,460 new cases of breast cancer would be diagnosed in ... are nearly 2.5 million breast cancer survivors in the United ... J. DellaCroce, MD, FACS and Scott K. Sullivan, MD, FACS, ...
Cached Medicine News:Health News:American Lung Association Salutes Fellow Advocates in the Fight Against Tuberculosis on 2009 World TB Day 2Health News:Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education 2Health News:Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education 3Health News:Growers Establish Foundation To Help Farmworkers With Child Care, Health Care and Education 4Health News:South Asians with diabetes more likely to lose their eyesight earlier than white Europeans 2Health News:Record number of patients seek laser treatments to take lightyears off their faces 2Health News:Pioneering Hospital Opens In New Orleans 2Health News:Pioneering Hospital Opens In New Orleans 3Health News:Pioneering Hospital Opens In New Orleans 4
... The ANA and ENA assays ... patients negative for antinuclear antibodies, which ... diseases such as Systemic lupus erythematosus ... disease, progressive systemic sclerosis, scleroderma, polymyositis, ...
... Aspirin is the medication most commonly prescribed ... such as heart attacks and strokes. However, a ... as 30% of people taking daily aspirin therapy ... be receiving aspirin's full benefits. These people ...
... System is an embolic protection device that ... debris that may be dislodged during interventional ... components. The first is a guidewire-mounted filter, ... Other ancillary components supplied with the system ...
... EYESI is a simulator for intraocular ... gives the surgeon the feeling that he ... surgery the surgeon uses instruments that feel ... The view through the EYESI microscope is ...
Medicine Products: